Effects of Hydrotherapy During Post-COVID-19 Rehabilitation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSchön Klinik Berchtesgadener Land
About this trial
This randomized controlled study evaluates the effects of cold water hydrotherapy as an adjunct to standard rehabilitation in patients with Post-COVID Syndrome. The primary aim is to assess changes in quality of life compared to standard rehabilitation alone.
Eligibility criteria
Qualifiers
Diagnosis of Post-COVID Syndrome (ICD-10 code: U08.9)
Barthel-Index >80
Referred to the reference center for Post-COVID rehabilitation
Owning a smartphone to receive digital questionnaires and to use the measurement app for heart rate variability
Disqualifiers
Existing contraindications for Kneipp hydrotherapy like severe cardiovascular diseases (e.g., decompensated heart failure, unstable angina pectoris, acute myocardial infarction), severe venous diseases (e.g., acute deep vein thrombosis of the leg), severe neurological diseases (e.g., uncontrolled epilepsy)
Prior regular practice of Kneipp applications
Trial design
Treatments tested in this trial
- Standard rehabilitation plus cold water hydrotherapy
- Standard rehabilitation only
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Schön Klinik Berchtesgadener Land
Lead sponsor
Bavarian Health and Food Safety Authority (LGL)
Collaborator
Source ClinicalTrials.gov